Ionis Pharmaceuticals' Investigator‑Initiated Research Program funds independent studies advancing science in cardiovascular, hereditary angioedema, and neurological diseases.
Alnylam Pharmaceuticals' Sponsorships fund educational and scientific initiatives advancing research and awareness in ATTR amyloidosis, AHP, and PH1.
Independent Medical and Patient Education/Advocacy Grants support organizations’ medical education and patient education or advocacy initiatives to advance knowledge, improve care, and address community needs.
Fellowships, Award Programs, and Scholarships support research organizations and medical educators with funding to advance research and address educational needs in rare disease, neuroscience, and oncology.
Ionis Pharmaceuticals' IME Program funds independent education initiatives to advance clinical knowledge and care in hereditary angioedema and severe hypertriglyceridemia.